Main Street Group’s GSK GSK Stock Holding History

Main Street Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.62K	Hold	50	–	–	﹤0.01%	713
2026 Q1	$2.76K	Buy	+50	New	+$2.71K	﹤0.01%	711
2025 Q4	–	Sell	-50	Closed	-$2.16K	–	303
2025 Q3	$2.16K	Hold	50	–	–	﹤0.01%	683
2025 Q2	$1.92K	Hold	50	–	–	﹤0.01%	647
2025 Q1	$1.94K	Hold	50	–	–	﹤0.01%	668
2024 Q4	$1.69K	Sell	50 -464	-90%	-$16.7K	﹤0.01%	663
2024 Q3	$21K	Hold	514	–	–	0.01%	396
2024 Q2	$19.7K	Hold	514	–	–	0.01%	411
2024 Q1	$21.8K	Buy	514 +50	+11%	+$2.06K	0.01%	421
2023 Q4	$17.2K	Buy	+464	New	+$16.7K	0.01%	669

Other funds holding GSK

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

Stablepoint Partners Braintree, Massachusetts $723M AUM 29.31% 1-Year Est. Return

First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return

Bonness Enterprises Washington, District of Columbia $310M AUM 24.22% 1-Year Est. Return

Redhawk Wealth Advisors Minneapolis, Minnesota $1.02B AUM 35.15% 1-Year Est. Return

Tower Trust & Investment Company Davenport, Iowa $165M AUM 28.96% 1-Year Est. Return

Quintet Private Bank (Europe) Luxembourg $1.6B AUM 23.66% 1-Year Est. Return

Rockland Trust Hanover, Massachusetts $2.55B AUM 17.04% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.6B AUM 18.11% 1-Year Est. Return

Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return